Cancer Drug Price Caps: Are They the Best Solution?
Cancer drug price caps are set to reduce costs by up to 70%.
Cancer drug price caps are set to reduce costs by up to 70%.
Cancer drug prices are set to fall significantly, with a reduction of up to 70% starting Nov 9.
Cancer drug prices may drop significantly as the government caps profit margins at 30%.
Adapalene Gel Pump Packs are now available in the US, targeting the OTC market.
Symbiotec Pharmalab share price is up today due to a major US deal, reaching a 52-week high. Discover the factors behind this surge.
Aumolertinib approval revoked due to data protection breach. Discover the implications for patients and the pharmaceutical industry.
Cancer drug prices have surged dramatically, shocking the SC and raising concerns about affordability and access to treatment.
SSY Group drug approvals are attracting investor attention. Discover how these developments can impact your investment strategy.
China approval antipsychotic drug offers new hope for patients seeking effective mental health treatments. Discover the implications of this breakthrough.